This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Aug;4(8):458-9.

doi: 10.1038/ncponc0882. Epub 2007 Jun 26.

Sunitinib--a new standard of care for metastatic renal cell carcinoma

Walter M Stadler¹, Russell Z Szmulewitz

Affiliations

PMID: 17593923
DOI: 10.1038/ncponc0882

Comment

Sunitinib--a new standard of care for metastatic renal cell carcinoma

Walter M Stadler et al. Nat Clin Pract Oncol. 2007 Aug.

. 2007 Aug;4(8):458-9.

doi: 10.1038/ncponc0882. Epub 2007 Jun 26.

Authors

Walter M Stadler¹, Russell Z Szmulewitz

Affiliation

¹ University of Chicago Hospitals, Department of Medicine, Chicago, IL 60637, USA. wstadler@medicine.bsd.uchicago.edu

PMID: 17593923
DOI: 10.1038/ncponc0882

No abstract available

PubMed Disclaimer

Comment in

Interleukin 2 for patients with renal cancer.
Rosenberg SA. Rosenberg SA. Nat Clin Pract Oncol. 2007 Sep;4(9):497. doi: 10.1038/ncponc0926. Nat Clin Pract Oncol. 2007. PMID: 17728709 Free PMC article. No abstract available.

Comment on

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA. Motzer RJ, et al. N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044. N Engl J Med. 2007. PMID: 17215529 Clinical Trial.

Similar articles

Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
Wood CG, Margulis V. Wood CG, et al. Cancer. 2009 May 15;115(10 Suppl):2355-60. doi: 10.1002/cncr.24240. Cancer. 2009. PMID: 19402066
New therapeutic developments in renal cell cancer.
Prenen H, Gil T, Awada A. Prenen H, et al. Crit Rev Oncol Hematol. 2009 Jan;69(1):56-63. doi: 10.1016/j.critrevonc.2008.07.007. Epub 2008 Aug 26. Crit Rev Oncol Hematol. 2009. PMID: 18752971 Review.
EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM, Bellmunt J, van Poppel H, Marreaud S, Aapro M. de Reijke TM, et al. Eur J Cancer. 2009 Mar;45(5):765-73. doi: 10.1016/j.ejca.2008.12.010. Epub 2009 Jan 20. Eur J Cancer. 2009. PMID: 19157861 Review.
Metastatic non-clear cell renal cell carcinoma: current therapeutic options.
Schrader AJ, Olbert PJ, Hegele A, Varga Z, Hofmann R. Schrader AJ, et al. BJU Int. 2008 Jun;101(11):1343-5. doi: 10.1111/j.1464-410X.2008.07462.x. Epub 2008 Jan 30. BJU Int. 2008. PMID: 18241246 Review.
A new standard cell.
Van Dyck FC. Van Dyck FC. Science. 1885 Jun 19;5(124):494. doi: 10.1126/science.ns-5.124.494. Science. 1885. PMID: 17829988 No abstract available.

See all similar articles

Cited by

Dietary phytoestrogens present in soy dramatically increase cardiotoxicity in male mice receiving a chemotherapeutic tyrosine kinase inhibitor.
Harvey PA, Leinwand LA. Harvey PA, et al. Mol Cell Endocrinol. 2015 Jan 5;399:330-5. doi: 10.1016/j.mce.2014.10.011. Epub 2014 Oct 30. Mol Cell Endocrinol. 2015. PMID: 25458703 Free PMC article.
A comprehensive overview of targeted therapy in metastatic renal cell carcinoma.
Mihaly Z, Sztupinszki Z, Surowiak P, Gyorffy B. Mihaly Z, et al. Curr Cancer Drug Targets. 2012 Sep;12(7):857-72. doi: 10.2174/156800912802429265. Curr Cancer Drug Targets. 2012. PMID: 22515521 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.